Rituximab in systemic sclerosis: A protocol for systematic review

BACKGROUND: Systemic sclerosis (SSc) is a clinically complex and challenging disease, the most frequent complication of which is interstitial lung disease, which leads to a worse prognosis. In this situation, cyclophosphamide is considered the criterion standard for treatment, despite the controvers...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldas, Marina Maria Vieira de Figueiredo, Neto, Francisco Alves Bezerra, de Azevedo, Kesley Pablo Morais, Pimenta, Isac Davidson Santiago Fernandes, Oliveira, Ana Katherine Da Silveira Gonçalves De, Piuvezam, Grasiela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756608/
https://www.ncbi.nlm.nih.gov/pubmed/31567948
http://dx.doi.org/10.1097/MD.0000000000017110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756608/
https://www.ncbi.nlm.nih.gov/pubmed/31567948
http://dx.doi.org/10.1097/MD.0000000000017110

Ejemplares similares